vs
CareDx, Inc.（CDNA）与RMR GROUP INC.（RMR）财务数据对比。点击上方公司名可切换其他公司
CareDx, Inc.的季度营收约是RMR GROUP INC.的1.8倍（$117.7M vs $66.7M），RMR GROUP INC.净利率更高（18.3% vs 2.4%，领先15.9%），RMR GROUP INC.同比增速更快（40.8% vs 39.0%）
CareDx是一家专注于器官移植领域的精准医疗企业，核心产品包括移植排斥反应监测诊断试剂、数字健康管理工具及配套临床服务，面向北美和欧洲市场的医疗机构及移植患者，助力提升术后患者生存质量。
RMR集团是总部位于美国的另类资产管理企业，核心业务聚焦不动产及相关投资，覆盖商业地产、住宅物业、基础设施等赛道，服务全球核心市场的机构投资者、高净值人士及零售客户。
CDNA vs RMR — 直观对比
营收规模更大
CDNA
是对方的1.8倍
$66.7M
营收增速更快
RMR
高出1.8%
39.0%
净利率更高
RMR
高出15.9%
2.4%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $117.7M | $66.7M |
| 净利润 | $2.8M | $12.2M |
| 毛利率 | — | — |
| 营业利润率 | 1.0% | 48.1% |
| 净利率 | 2.4% | 18.3% |
| 营收同比 | 39.0% | 40.8% |
| 净利润同比 | — | 91.1% |
| 每股收益（稀释后） | $0.05 | $0.71 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CDNARMR
| Q1 26 | $117.7M | — | ||
| Q4 25 | $108.4M | $66.7M | ||
| Q3 25 | $100.1M | — | ||
| Q2 25 | $86.7M | — | ||
| Q1 25 | $84.7M | — | ||
| Q4 24 | $86.6M | — | ||
| Q3 24 | $82.9M | — | ||
| Q2 24 | $92.3M | — |
净利润CDNARMR
| Q1 26 | $2.8M | — | ||
| Q4 25 | $-4.1M | $12.2M | ||
| Q3 25 | $1.7M | — | ||
| Q2 25 | $-8.6M | — | ||
| Q1 25 | $-10.4M | — | ||
| Q4 24 | $87.7M | — | ||
| Q3 24 | $-10.6M | — | ||
| Q2 24 | $-4.6M | — |
营业利润率CDNARMR
| Q1 26 | 1.0% | — | ||
| Q4 25 | -5.6% | 48.1% | ||
| Q3 25 | -0.2% | — | ||
| Q2 25 | -12.8% | — | ||
| Q1 25 | -15.8% | — | ||
| Q4 24 | 97.5% | — | ||
| Q3 24 | -16.6% | — | ||
| Q2 24 | -7.9% | — |
净利率CDNARMR
| Q1 26 | 2.4% | — | ||
| Q4 25 | -3.8% | 18.3% | ||
| Q3 25 | 1.7% | — | ||
| Q2 25 | -9.9% | — | ||
| Q1 25 | -12.2% | — | ||
| Q4 24 | 101.3% | — | ||
| Q3 24 | -12.8% | — | ||
| Q2 24 | -5.0% | — |
每股收益（稀释后）CDNARMR
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-0.08 | $0.71 | ||
| Q3 25 | $0.03 | — | ||
| Q2 25 | $-0.16 | — | ||
| Q1 25 | $-0.19 | — | ||
| Q4 24 | $1.60 | — | ||
| Q3 24 | $-0.20 | — | ||
| Q2 24 | $-0.09 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $77.9M | $49.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $232.7M |
| 总资产 | $411.1M | $687.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CDNARMR
| Q1 26 | $77.9M | — | ||
| Q4 25 | $177.2M | $49.3M | ||
| Q3 25 | $194.2M | — | ||
| Q2 25 | $186.3M | — | ||
| Q1 25 | $230.9M | — | ||
| Q4 24 | $260.7M | — | ||
| Q3 24 | $240.9M | — | ||
| Q2 24 | $228.9M | — |
总债务CDNARMR
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $0 | — | ||
| Q2 24 | $0 | — |
股东权益CDNARMR
| Q1 26 | — | — | ||
| Q4 25 | $303.1M | $232.7M | ||
| Q3 25 | $311.1M | — | ||
| Q2 25 | $327.4M | — | ||
| Q1 25 | $379.3M | — | ||
| Q4 24 | $378.4M | — | ||
| Q3 24 | $273.2M | — | ||
| Q2 24 | $264.7M | — |
总资产CDNARMR
| Q1 26 | $411.1M | — | ||
| Q4 25 | $413.2M | $687.1M | ||
| Q3 25 | $432.3M | — | ||
| Q2 25 | $444.3M | — | ||
| Q1 25 | $489.6M | — | ||
| Q4 24 | $491.1M | — | ||
| Q3 24 | $477.0M | — | ||
| Q2 24 | $466.8M | — |
负债/权益比CDNARMR
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.3M | $10.7M |
| 自由现金流经营现金流 - 资本支出 | $514.0K | — |
| 自由现金流率自由现金流/营收 | 0.4% | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 1.54× | 0.88× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CDNARMR
| Q1 26 | $4.3M | — | ||
| Q4 25 | $21.4M | $10.7M | ||
| Q3 25 | $37.4M | — | ||
| Q2 25 | $9.9M | — | ||
| Q1 25 | $-26.6M | — | ||
| Q4 24 | $21.9M | — | ||
| Q3 24 | $12.5M | — | ||
| Q2 24 | $18.9M | — |
自由现金流CDNARMR
| Q1 26 | $514.0K | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
自由现金流率CDNARMR
| Q1 26 | 0.4% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金转化率CDNARMR
| Q1 26 | 1.54× | — | ||
| Q4 25 | — | 0.88× | ||
| Q3 25 | 22.30× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.25× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CDNA
| Financial Results Total | $85.0M | 72% |
| Patient and digital solutions revenue | $16.0M | 14% |
| Product revenue | $10.3M | 9% |
| Other | $6.4M | 5% |
RMR
| Management Service Incentive | $23.6M | 35% |
| Industrial Logistics Properties Trust | $15.1M | 23% |
| Managed Private Real Estate Capital | $11.1M | 17% |
| Office Properties Income Trust | $5.6M | 8% |
| Other Private Entities | $5.3M | 8% |
| RMR Residential | $3.4M | 5% |
| Sonesta International Hotels Corporation | $2.1M | 3% |
| Investment Advisory Management And Administrative Service | $1.2M | 2% |
